Combined alveolitis and asthma due to hexamethylene diisocyanate (HDI), with demonstration of crossed respiratory and immunologic reactivities to diphenylmethane diisocyanate (MDI).
about
Exposure biomarkers and risk from gluing and heating of polyurethane: a cross sectional study of respiratory symptomsIssues in diisocyanate antibody testing.Isocyanates.Qualitative assessment of isocyanate skin exposure in auto body shops: a pilot study.Immunologic hemorrhagic pneumonia caused by isocyanates.Respiratory effects of inhaled isocyanates.Can serial PEF measurements separate occupational asthma from allergic alveolitis?Isocyanates, polyurethane paints, and asthma.Chemical determinants of occupational hypersensitivity pneumonitis.Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectivesContact hypersensitivity response to isophorone diisocyanate in mice.Determination of unreacted 2,4-toluene diisocyanate (2,4TDI) and 2,6-toluene diisocyanate (2,6TDI) in foams at ultratrace level by using HPLC-CIS-MS-MS.Quantitative determination of hexamethylene diisocyanate (HDI), 2,4-toluene diisocyanate (2,4-TDI) and 2,6-toluene diisocyanate (2,6-TDI) monomers at ppt levels in air by alkaline adduct coordination ionspray tandem mass spectrometry.Implementation and evaluation of an analytical method for a novel derivatizing agent to measure 4,4'-methylene diphenyl diisocyanate atmospheres.Identification of methylene diphenyl diisocyanate thermal degradation products in a generation chamber by liquid chromatography coupled with tandem mass spectrometry.Comparison between the ASSET EZ4 NCO and Impinger Sampling Devices for Aerosol Sampling of 4,4'-Methylene Diphenyl Diisocyanate in Spray Foam Application.Toluene diisocyanate and methylene diphenyl diisocyanate: asthmatic response and cross-reactivity in a mouse model
P2860
Q35492034-104C2A8F-57D6-4C1A-9D7E-F4D3112F8AA0Q36900965-378A2075-4AA0-4F05-8297-A82886FF625BQ37717238-27D341F2-C3F6-4019-8999-7B97F79A66D1Q38498086-476F72FD-DB7A-4208-BE68-53C3E217DC0CQ38516629-678A10E9-94AD-4E7E-AE77-57F26D86E23EQ39733670-69816F67-292D-4E16-B605-50B5101FF521Q41137060-4C1B4F9B-4609-4698-AE42-DF7B01D0F97BQ41166237-04FB56FA-2CBD-4FB6-A516-271D20B74DE5Q41309437-BCD4C512-DFB7-4F87-92CC-9ACADDE0016AQ42096672-5295FE8A-2A3D-4D32-A06A-C646741BF0A3Q44720463-E52FDB8A-0366-45C8-8DD1-B4D6DAF5CED0Q44737570-CEF336DE-D54B-49A0-A44B-74F019B69338Q45250208-E864909F-6B4D-48E8-AE68-267CE3B738CBQ51460042-56536A40-AEE5-4678-ADB0-F092B5168A9CQ51784555-98E13888-DB31-41F4-92DA-637EA8BA524CQ53169952-B3C56123-7A53-41B8-AC80-03C45228C2F9Q57009972-01755750-E9BE-4DD2-B42C-ACF65763F67A
P2860
Combined alveolitis and asthma due to hexamethylene diisocyanate (HDI), with demonstration of crossed respiratory and immunologic reactivities to diphenylmethane diisocyanate (MDI).
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@ast
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@en
type
label
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@ast
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@en
prefLabel
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@ast
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@en
P2093
P1476
Combined alveolitis and asthma ...... nylmethane diisocyanate (MDI).
@en
P2093
P304
P356
10.1016/0091-6749(83)90508-0
P407
P577
1983-10-01T00:00:00Z